Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.

ABSTRACT:

SUBMITTER: Payares-Herrera C 

PROVIDER: S-EPMC7785778 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature